this post was submitted on 15 Aug 2024
10 points (100.0% liked)

Politics

679 readers
182 users here now

For civil discussion of US politics. Be excellent to each other.

Rule 1: Posts have the following requirements:
▪️ Post articles about the US only

▪️ Title must match the article headline

▪️ Recent (Past 30 Days)

▪️ No Screenshots/links to other social media sites or link shorteners

Rule 2: Do not copy the entire article into your post. One or two small paragraphs are okay.

Rule 3: Articles based on opinion (unless clearly marked and from a serious publication-No Fox News or equal), misinformation or propaganda will be removed.

Rule 4: Keep it civil. It’s OK to say the subject of an article is behaving like a jerk. It’s not acceptable to say another user is a jerk. Cussing is fine.

Rule 5: Be excellent to each other. Posts or comments that are homophobic, transphobic, racist, sexist, ableist, will be removed.

Rule 6: Memes, spam, other low effort posting, reposts, advocating violence, off-topic, trolling, offensive, regarding the moderators or meta in content may be removed at any time.

Rule 7. No conjecture type posts (this could, might, may, etc.). Only factual. If the headline is wrong, clarify within the body. More info

Bookmark Vault of Trump's First Term

USAfacts.org

The Alt-Right Playbook

Media owners, CEOs and/or board members

Video: Macklemore's new song critical of Trump and Musk is facing heavy censorship across major platforms.

founded 2 years ago
MODERATORS
 
  • Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer: $231 negotiated price, down from $521 list price.
  • Xarelto, a blood thinner from Johnson & Johnson; $197 negotiated price, down from $517 list price.
  • Januvia, a diabetes drug from Merck: $113 negotiated price, down from $527 list price.
  • Jardiance, a diabetes drug from Boehringer Ingelheim and Eli Lilly: $197 negotiated price, down from $573 list price.
  • Enbrel, a rheumatoid arthritis drug from Amgen: $2,355 negotiated price, down from $7,106 list price.
  • Imbruvica, a drug for blood cancers from AbbVie and Johnson & Johnson: $9,319 negotiated price, down from $14,934 list price.
  • Farxiga, a drug for diabetes, heart failure and chronic kidney disease from AstraZeneca: $178 negotiated price, down from $556 list price.
  • Entresto, a heart failure drug from Novartis: $295 negotiated price, down from $628 list price.
  • Stelara, a drug for psoriasis and Crohn’s disease from J&J: $4,695 negotiated price, down from $13,836 list price.
  • Fiasp and NovoLog, diabetes drugs from Novo Nordisk: $119 negotiated price, down from $495 list price.

The new negotiated prices were compared to the 2023 list prices of the drugs.

all 1 comments
sorted by: hot top controversial new old